How AI could speed treatment for patients with this deadly cancer
Medical Xpress
March 4, 2026
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an assistant research professor in bioengineering at Northeastern University, says that AML also has a high recurrence rate and no one-size-fits-all treatment option.
Verticals
healthmedical
Originally published on Medical Xpress on 3/4/2026